IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Alexion Pharmaceuticals Inc

CUSIP: 015351909 | 31 institutional holders

Quarters

Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile